GSK — GLAXOSMITHKLINE PLC COM

Ownership history in Camber Capital Management LP  ·  32 quarters on record

AI Ownership Summary

Camber Capital Management LP reported GLAXOSMITHKLINE PLC COM (GSK) in 32 quarterly 13F filings from 2023 Q4 through 2025 Q2. Peak portfolio weight reached 3.91% in 2024 Q4. The latest visible filing shows GSK at 3.60% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this GSK ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Camber Capital Management LP's position in GLAXOSMITHKLINE PLC COM, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q2

GSK was reported at 3.60% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
3.91% in 2024 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2025 Q2

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

GSK stock page Camber Capital Management LP fund profile Camber Capital Management LP full holdings
How Camber Capital Management LP held GSK — position size vs. price
% of Fund (quarterly)    GSK price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 8 quarters  ▾
Quarter Action Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q2 UNCHANGED 1,000,000 — 0% 3.60% $38.4M 2025-08-14 (Est.) $38.16
2025 Q1 REDUCED 1,000,000 -1,500,000 -60.0% 1.38% $38.7M 2025-05-15 $36.13
2024 Q4 REDUCED 2,500,000 -2,500,000 -50.0% 1.96% $84.5M 2025-02-14 $34.40
2024 Q4 ADDED 5,000,000 +2,000,000 +66.7% 3.91% $169.1M 2025-02-14 $34.40
2024 Q3 ADDED 3,000,000 +325,000 +12.1% 3.90% $122.6M 2024-11-14 $32.34
2024 Q2 ADDED 2,675,000 +500,000 +23.0% 2.85% $103.0M 2024-08-14 $38.40
2024 Q1 UNCHANGED 2,175,000 — 0% 2.29% $93.2M 2024-05-15 $42.22
2023 Q4 REDUCED 2,175,000 -675,000 -23.7% 2.05% $80.6M 2024-02-14 $38.25
24 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

🏢 Other funds also holding GSK

As of 2026 Q1 — sorted by position size

Clean Yield Group 3Y 7Y 2.52% Stockman Wealth Management, Inc. 3Y 7Y 1.65% Roberts Wealth Advisors, LLC 3Y 1.2% Gilman Hill Asset Management, LLC 3Y 7Y 1.01% Old Port Advisors 3Y 7Y 0.87% BONNESS ENTERPRISES INC 3Y 7Y 0.84% TOWER TRUST & INVESTMENT Co 0.83% Douglas Lane & Associates, LLC 3Y 7Y 0.8% TruWealth Advisors, LLC 3Y 0.71% Stanley-Laman Group, Ltd. 3Y 7Y 0.71%

FAQ About Camber Capital Management LP and GSK

These are the practical questions this page is built to answer before you even open the full history table.

How long has Camber Capital Management LP reported owning GSK?

Camber Capital Management LP reported GSK across 8 quarterly 13F filings, from 2023 Q4 through 2025 Q2.

What was the largest reported GSK position in Camber Capital Management LP's portfolio?

The largest reported portfolio weight for GSK was 3.91% in 2024 Q4.

What is the latest reported GSK position on this page?

The most recent filing on this page is 2025 Q2, when Camber Capital Management LP reported 1,000,000 shares, equal to 3.60% of portfolio, with an estimated market value of $38.4M.

What does the chart on this GSK ownership page compare?

The chart compares Camber Capital Management LP's quarterly GSK portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to Camber Capital Management LP Holdings